UnitedHealth Group (UNH) Stock Price, News & Analysis

Company Overview

UnitedHealth Group Incorporated is a diversified healthcare company that operates two primary business platforms: UnitedHealthcare, which offers health benefit plans and services, and Optum, which delivers data-driven health services and technology solutions. Headquartered in Minnetonka, Minnesota, the company provides a range of health insurance products, care management programs and related administrative services to individuals, employers, governmental entities and care providers.

UnitedHealthcare develops and administers a variety of benefit plans, including commercial employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and specialty programs tailored to specific populations. The division also focuses on network development, provider relations and population health initiatives designed to improve care access and quality while managing costs.

Optum comprises three businesses—OptumHealth, OptumInsight and OptumRx—that work together to integrate clinical care, data analytics, technology and pharmacy services. OptumHealth partners with care providers and health systems to coordinate patient care, while OptumInsight offers software and consulting solutions to support clinical decision-making, revenue cycle management and operational efficiency. OptumRx manages pharmacy benefit services, including formulary design, claims processing and home delivery of medications.

Founded in 1977 as United HealthCare Corporation and later renamed UnitedHealth Group in 1998, the company has expanded its presence across all 50 U.S. states and maintains operations in select international markets. Under the leadership of Chief Executive Officer Andrew Witty and President Dirk McMahon, UnitedHealth Group continues to pursue innovations in care delivery, population health and health technology to address evolving challenges in the healthcare industry.

Key Stats

• Today's Range: $300.91 to $310.00
• 50-Day Range: $237.40 to $325.83
• 52-Week Range: $234.60 to $630.73
• Volume: 12.02 million shs
• Average Volume: 18.89 million shs
• Market Capitalization: $280.55 billion
• P/E Ratio: 13.42
• Dividend Yield: 2.85%
• Price Target: $353.00
• Consensus Rating: Moderate Buy

UnitedHealth Group Stock Analysis - MarketRank™

UnitedHealth Group scored higher than 99% of companies evaluated by MarketBeat, and ranked 22nd out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

UnitedHealth Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 15 buy ratings, 6 hold ratings, and 3 sell ratings.

Amount of Analyst Coverage

UnitedHealth Group has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 12.46%

Earnings Growth

Earnings for UnitedHealth Group are expected to grow by 12.46% in the coming year, from $29.54 to $33.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of UnitedHealth Group is 13.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 270.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of UnitedHealth Group is 13.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.19.

Price to Earnings Growth Ratio

UnitedHealth Group has a PEG Ratio of 2.00. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

UnitedHealth Group has a P/B Ratio of 2.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.68% of the float of UnitedHealth Group has been sold short.

Short Interest Ratio / Days to Cover

UnitedHealth Group has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in UnitedHealth Group has recently increased by 19.83%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

UnitedHealth Group pays a meaningful dividend of 2.85%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

UnitedHealth Group has been increasing its dividend for 15 years.

Dividend Coverage

The dividend payout ratio of UnitedHealth Group is 38.30%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 26.61% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -0.33

Percentage of Shares Shorted

1.68% of the float of UnitedHealth Group has been sold short.

Short Interest Ratio / Days to Cover

UnitedHealth Group has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in UnitedHealth Group has recently increased by 19.83%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.00

News Sentiment

UnitedHealth Group has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.11 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 72 news articles for UnitedHealth Group this week, compared to 112 articles on an average week.

Search Interest

561 people have searched for UNH on MarketBeat in the last 30 days. This is an increase of 7% compared to the previous 30 days.

MarketBeat Follows

154 people have added UnitedHealth Group to their MarketBeat watchlist in the last 30 days. This is an increase of 35% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, UnitedHealth Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $179,645.00 in company stock.

Percentage Held by Insiders

Only 0.28% of the stock of UnitedHealth Group is held by insiders.

Percentage Held by Institutions

87.86% of the stock of UnitedHealth Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

UNH Stock Analysis - Frequently Asked Questions

How have UNH shares performed this year?

UnitedHealth Group's stock was trading at $505.86 at the beginning of the year. Since then, UNH stock has decreased by 38.8% and is now trading at $309.7730.

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Incorporated (NYSE:UNH) released its quarterly earnings results on Tuesday, July, 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by $0.37. The business's revenue for the quarter was up 12.9% compared to the same quarter last year.
Read the conference call transcript.

Does UnitedHealth Group have any subsidiaries?

UnitedHealth Group subsidiaries include these companies: LHC Group, PreferredOne, divvyDOSE, Diplomat Pharmacy, PatientsLikeMe, Equian, Avella Specialty Pharmacy, and more.

Who are UnitedHealth Group's major shareholders?

Top institutional shareholders of UnitedHealth Group include Vanguard Group Inc. (10.02%), State Street Corp (4.96%), Geode Capital Management LLC (2.35%) and Norges Bank (1.36%). Insiders that own company stock include Stephen J Hemsley, John F Rex, Andrew Witty, Thomas E Roos, Patrick Hugh Conway, Erin Mcsweeney, John H Noseworthy and Kristen Gil.
View institutional ownership trends.

How do I buy shares of UnitedHealth Group?

Shares of UNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of UnitedHealth Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that UnitedHealth Group investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW), Cuisine Solutions (CUSI) and InnerScope Hearing Technologies (INND).

Company Calendar

• Record date for 6/24 Dividend: 6/16/2025
• Ex-Dividend for 6/24 Dividend: 6/16/2025
• Dividend Payable: 6/24/2025
• Last Earnings: 7/29/2025
• Today: 9/01/2025
• Record date for 9/23 Dividend: 9/15/2025
• Ex-Dividend for 9/23 Dividend: 9/15/2025
• Dividend Payable: 9/23/2025
• Next Earnings (Estimated): 10/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:UNH
• CIK: 731766
• Web: www.unitedhealthgroup.com
• Phone: (952) 936-1300
• Fax: 952-936-1819
• Employees: 400,000
• Year Founded: 1977

Price Target and Rating

• Average Price Target for UnitedHealth Group: $353.00
• High Price Target: $675.00
• Low Price Target: $198.00
• Potential Upside/Downside: +14.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 24 Analysts

Profitability

• EPS (Trailing Twelve Months): $23.08
• Trailing P/E Ratio: 13.42
• Forward P/E Ratio: 10.49
• P/E Growth: 2
• Net Income: $14.41 billion
• Net Margins: 5.04%
• Pretax Margin: 6.29%
• Return on Equity: 23.32%
• Return on Assets: 7.66%

Debt

• Debt-to-Equity Ratio: 0.73
• Current Ratio: 0.85
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $400.28 billion
• Price / Sales: 0.70
• Cash Flow: $32.37 per share
• Price / Cash Flow: 9.57
• Book Value: $106.78 per share
• Price / Book: 2.90

Miscellaneous

• Outstanding Shares: 905,670,000
• Free Float: 903,138,000
• Market Cap: $280.55 billion
• Optionable: Optionable
• Beta: 0.44